LAWRENCE E. LEIBOWITZ - 16 Aug 2023 Form 4 Insider Report for Enfusion, Inc.

Role
Director
Signature
/s/ Matthew Campobasso, as Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
16 Aug 2023
Net transactions value
$0
Form type
4
Filing time
18 Aug 2023, 16:15:47 UTC
Previous filing
15 Aug 2023
Next filing
17 Nov 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ENFN Class A Common Stock Award $0 +10,353 +7.1% $0.000000 155,767 16 Aug 2023 Direct F1
transaction ENFN Class A Common Stock Award $0 +6,335 +4.1% $0.000000 162,102 17 Aug 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of fully vested shares issued under the Enfusion, Inc. 2021 Stock Option and Incentive Plan in connection with the previously disclosed pre-IPO termination of the Enfusion Ltd. LLC Change in Control Bonus Plan.